Category: FierceMarkets

Despite enhanced guidance from CMS, nursing homes hit by disaster often struggle to execute emergency plans and protect residents, according to testimony from the HHS Office of Inspector General to lawmakers last week. 

With all eyes on the ACA lawsuit in Texas, a federal judge issued an important victory for insurers over the fate of cost-sharing reduction payments. The DOJ is likely to appeal the decision.

While physician group ACOs saved Medicare millions, hospital-integrated ACOs cost the program even more than usual, the Harvard-based researchers found.

Several hospital groups, including the American Hospital Association, refiled a lawsuit against the Department of Health and Human Services over cuts to the 340B drug discount program.

In the first of several announcements today, the FDA commissioner said two more insurers are joining a program that allows payers to tell manufacturers what information they need to make coverage decisions.

The drug industry continued its campaign to spread the blame for high prescription drug prices with its latest commissioned analysis and ad spots aimed at explaining the role other players in the system have in influencing prices.

Although WellCare hasn’t offered exchange plans since 2016, its CEO says this move positions it for “growth within government-sponsored programs.”

Congressional leaders in the House Energy and Commerce Committee sent letters to seven PBMs with detailed questions around list price negotiation and how their role in the supply chain impacts spending in federal health programs.

Arizona Governor Doug Ducey has generally supported efforts to repeal the ACA. The individual he appoints could support repeal as well—but not necessarily.

The legislation, which would cap profits on dialysis clinics affiliated with charities, has been highly contested by the industry.